关注
Arik Dahan
Arik Dahan
Prof. of Pharmaceutics and Biopharmaceutics
在 bgu.ac.il 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs
A Dahan, JM Miller, GL Amidon
The AAPS journal 11, 740-746, 2009
5102009
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
A Dahan, A Hoffman
Journal of controlled release 129 (1), 1-10, 2008
4232008
Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies
S Ben-Shabat, L Yarmolinsky, D Porat, A Dahan
Drug delivery and translational research 10, 354-367, 2020
3442020
Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance
A Dahan, H Altman
European journal of clinical nutrition 58 (1), 1-9, 2004
3302004
The solubility–permeability interplay and its implications in formulation design and development for poorly soluble drugs
A Dahan, JM Miller
The AAPS journal 14, 244-251, 2012
2942012
A win–win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane …
JM Miller, A Beig, RA Carr, JK Spence, A Dahan
Molecular pharmaceutics 9 (7), 2009-2016, 2012
2712012
The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability …
A Dahan, A Hoffman
European journal of pharmaceutics and biopharmaceutics 67 (1), 96-105, 2007
2562007
The solubility–permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone
A Dahan, JM Miller, A Hoffman, GE Amidon, GL Amidon
Journal of pharmaceutical sciences 99 (6), 2739-2749, 2010
2372010
Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the …
A Dahan, A Hoffman
Pharmaceutical research 23, 2165-2174, 2006
2252006
The solubility–permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation
JM Miller, A Beig, BJ Krieg, RA Carr, TB Borchardt, GE Amidon, ...
Molecular pharmaceutics 8 (5), 1848-1856, 2011
2092011
Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs
A Dahan, A Hoffman
European journal of pharmaceutical sciences 24 (4), 381-388, 2005
1932005
The solubility–permeability interplay and oral drug formulation design: Two heads are better than one
A Dahan, A Beig, D Lindley, JM Miller
Advanced drug delivery reviews 101, 99-107, 2016
1762016
Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class …
A Dahan, GL Amidon
Molecular Pharmaceutics 6 (1), 19-28, 2009
1662009
The solubility–permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations
JM Miller, A Beig, RA Carr, GK Webster, A Dahan
Molecular pharmaceutics 9 (3), 581-590, 2012
1422012
Applications of polymers as pharmaceutical excipients in solid oral dosage forms
N Debotton, A Dahan
Medicinal research reviews 37 (1), 52-97, 2017
1282017
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting
A Dahan, GL Amidon
American Journal of Physiology-Gastrointestinal and Liver Physiology 297 (2 …, 2009
1252009
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations
A Beig, R Agbaria, A Dahan
PLoS One 8 (7), e68237, 2013
1232013
Accounting for the solubility–permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption
A Beig, JM Miller, A Dahan
European journal of pharmaceutics and biopharmaceutics 81 (2), 386-391, 2012
1192012
Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to …
A Dahan, H Sabit, GL Amidon
Drug Metabolism and Disposition 37 (10), 2028-2036, 2009
1162009
Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in …
A Dahan, BT West, GL Amidon
European Journal of Pharmaceutical Sciences 36 (2-3), 320-329, 2009
1152009
系统目前无法执行此操作,请稍后再试。
文章 1–20